Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin.

Infection

Volumn 27, Issue 4-5, 1999, Pages 299-304

  Boswald M ^a   Dobig C ^a   Kandler C ^a   Kruger C ^a   Scharf, J ^a   Soergel, F ^a   Zink, S ^a   Guggenbichler, J P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN; IMIPENEM; PROTEINASE INHIBITOR; THIENAMYCIN DERIVATIVE;

ARTICLE; BACTEREMIA; COMPARATIVE STUDY; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROBIOLOGY; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

BACTEREMIA; CILASTATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMIPENEM; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS, NEONATAL; MALE; PROGNOSIS; PROTEASE INHIBITORS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; THIENAMYCINS;

EID: 0033286981     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)